Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

INTRODUCTION: Recently, studies have demonstrated that the addition of bevacizumab to chemotherapy could be associated with better outcomes in patients with advanced non-small cell lung cancer (NSCLC). However, the benefit seems to be dependent on the drugs used in the chemotherapy regimens. This sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, André Bacellar Costa, Macedo, Ligia T., Sasse, André Deeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149053/
https://www.ncbi.nlm.nih.gov/pubmed/21829644
http://dx.doi.org/10.1371/journal.pone.0022681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149053/
https://www.ncbi.nlm.nih.gov/pubmed/21829644
http://dx.doi.org/10.1371/journal.pone.0022681

Ejemplares similares